336 related articles for article (PubMed ID: 17985401)
1. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.
Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M
J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401
[TBL] [Abstract][Full Text] [Related]
2. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of right ventricular systolic dysfunction in early systemic sclerosis.
Meune C; Allanore Y; Devaux JY; Dessault O; Duboc D; Weber S; Kahan A
J Rheumatol; 2004 Oct; 31(10):1941-5. PubMed ID: 15468357
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
5. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.
Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM
Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417
[TBL] [Abstract][Full Text] [Related]
6. Pupillocynetic activity of substance P in systemic sclerosis.
Del Rosso A; Bertinotti L; Pietrini U; Messori A; Fanciullacci M; Casale R; Giacomelli R; Generini S; Sicuteri R; Pignone A; Cozzi F; Matucci-Cerinic M
J Rheumatol; 2003 Jun; 30(6):1231-7. PubMed ID: 12784395
[TBL] [Abstract][Full Text] [Related]
7. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment.
Rollando D; Bezante GP; Sulli A; Balbi M; Panico N; Pizzorni C; Negrini S; Brunelli C; Barsotti A; Cutolo M; Indiveri F; Ghio M
J Rheumatol; 2010 Jun; 37(6):1168-73. PubMed ID: 20436078
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of early cardiovascular involvement in patients with systemic sclerosis].
Wranicz JK; Strzondała M; Zielińska M; Cygankiewicz I; Ruta J; Dziankowska-Bartkowiak B; Sysa-Jedrzejowska A
Przegl Lek; 2000; 57(7-8):389-92. PubMed ID: 11109311
[TBL] [Abstract][Full Text] [Related]
9. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.
Kobayashi H; Yokoe I; Hirano M; Nakamura T; Nakajima Y; Fontaine KR; Giles JT; Kobayashi Y
J Rheumatol; 2009 Jan; 36(1):106-12. PubMed ID: 19040307
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
Crilly A; Hamilton J; Clark CJ; Jardine A; Madhok R
Rheumatology (Oxford); 2003 Nov; 42(11):1295-8. PubMed ID: 12867583
[TBL] [Abstract][Full Text] [Related]
12. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
[TBL] [Abstract][Full Text] [Related]
13. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
14. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
15. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.
Tzelepis GE; Kelekis NL; Plastiras SC; Mitseas P; Economopoulos N; Kampolis C; Gialafos EJ; Moyssakis I; Moutsopoulos HM
Arthritis Rheum; 2007 Nov; 56(11):3827-36. PubMed ID: 17968945
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
[TBL] [Abstract][Full Text] [Related]
17. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
Yuen SY; Rochwerg B; Ouimet J; Pope JE
J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
[TBL] [Abstract][Full Text] [Related]
18. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement?
Baldini C; Giusti L; Bazzichi L; Ciregia F; Giannaccini G; Giacomelli C; Doveri M; Del Rosso M; Bombardieri S; Lucacchini A
J Rheumatol; 2008 Sep; 35(9):1820-4. PubMed ID: 18634149
[TBL] [Abstract][Full Text] [Related]
19. Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imaging.
Nassenstein K; Breuckmann F; Huger M; Ladd SC; Schlosser T; Kreuter A; Barkhausen J
Rofo; 2008 Dec; 180(12):1054-60. PubMed ID: 19009498
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
